Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H16N2O.ClH |
| Molecular Weight | 180.676 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCCNCC(N)=O
InChI
InChIKey=DNSCECUSJKDSKP-UHFFFAOYSA-N
InChI=1S/C7H16N2O.ClH/c1-2-3-4-5-9-6-7(8)10;/h9H,2-6H2,1H3,(H2,8,10);1H
Milacemide, a prodrug for glycine, is an inhibitor of the B form of monoamine oxidase. This drug could enhance dopaminergic activity in the brain and could be used as therapy for Parkinson's disease. Milacemide participated in clinical trials as a treatment for senile dementia of the Alzheimer type (SDAT). However, results have shown the drug was not an effective treatment in enhancing cognition in SDAT patients. In addition, milacemide has been tested for antiepileptic efficacy; however, this study was discontinued.
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome. | 2007-07 |
|
| [New therapeutic options in Alzheimer's disease]. | 2006-04-21 |
|
| Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat. | 1998-07 |
|
| Milacemide therapy for Parkinson's disease. | 1993 |
|
| The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B. | 1989-10 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1634705
1200 mg/day milacemide treatment for 1 month (113 patients received milacemide, and 115 patients received placebo
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000055290
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
PRIMARY | |||
|
76990-85-7
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
PRIMARY | |||
|
6XK4G40F6W
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL75838
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
PRIMARY | |||
|
DTXSID70227787
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
PRIMARY | |||
|
C81470
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
PRIMARY | |||
|
X-85
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
PRIMARY | |||
|
53568
Created by
admin on Mon Mar 31 18:19:19 GMT 2025 , Edited by admin on Mon Mar 31 18:19:19 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD